1. Home
  2. RBB vs ENTA Comparison

RBB vs ENTA Comparison

Compare RBB & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RBB Bancorp

RBB

RBB Bancorp

HOLD

Current Price

$26.56

Market Cap

451.0M

Sector

Finance

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.73

Market Cap

371.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBB
ENTA
Founded
2008
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
451.0M
371.6M
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
RBB
ENTA
Price
$26.56
$12.73
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$22.00
$20.40
AVG Volume (30 Days)
203.3K
175.4K
Earning Date
04-20-2026
05-11-2026
Dividend Yield
2.68%
N/A
EPS Growth
24.49
29.93
EPS
0.66
N/A
Revenue
$5,167,000.00
$102,814,000.00
Revenue This Year
$20.50
$7.76
Revenue Next Year
$6.90
N/A
P/E Ratio
$39.82
N/A
Revenue Growth
N/A
16.48
52 Week Low
$16.74
$6.45
52 Week High
$28.24
$17.15

Technical Indicators

Market Signals
Indicator
RBB
ENTA
Relative Strength Index (RSI) 50.36 43.94
Support Level $20.11 $11.92
Resistance Level $28.22 $13.98
Average True Range (ATR) 0.80 0.73
MACD -0.20 -0.14
Stochastic Oscillator 34.06 19.83

Price Performance

Historical Comparison
RBB
ENTA

About RBB RBB Bancorp

RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: